A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

NCT05971940 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

559

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Orforglipron
DRUG: Placebo

Sponsor

Eli Lilly and Company